Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Exosome-based Company Raised 5 M€ for the Development of Its New Biomedicine and Vaccines
Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that […]
Vygon Acquires Macatt Medica, Peruvian Distributor of Single-use Medical Devices
Vygon, a specialist single-use medical devices group, today announces the acquisition of Macatt Medica, a […]
CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture
Today CELLINK, A BICO Company, launched the BIO CELLX a novel system that automates 3D […]
BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners
BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics […]
Health and Social Care Secretary Takes Reform Agenda on the Road
Health and Social Care Secretary Sajid Javid will be on the ‘road to recovery’ this […]
Secura Bio Announces Final Patient Enrolled in the COPIKTRA® (duvelisib) (PRIMO) Study in Relapsed and Refractory Peripheral T-cell Lymphoma
Secura Bio, Inc. (Secura Bio) – (www.securabio.com), an integrated pharmaceutical company dedicated to the worldwide […]
RealView Imaging Ltd., World Leader in Medical Holography, Receives FDA Clearance for its Groundbreaking HOLOSCOPE™-i Holographic System
RealView Imaging Ltd. today announced that it has received FDA 510(k) clearance for its HOLOSCOPE™-i holographic system. The […]
Circle Pharma Raises $66 Million in Series C Financing
Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, […]
Ferrer Launches Third Edition of Ferrer 4 Future (F4F) Program
Ferrer, a privately-held Spanish pharmaceutical company who aims to make a positive impact in society, […]
Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors
Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more